Shanghai (P.R.China) November 6, 2013 – Luqa Pharmaceuticals today announced its attendance to the BIO Convention in China. The conference will be held at the China National Convention Center in Beijing, China on November 11-13, 2013.
In its third year, the BIO Convention in China will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities with China’s emerging biotech sector.
The BIO Convention in China will feature company presentations by more than 20 biotech and pharmaceutical companies. Luqa Pharmaceuticals will present on Tuesday, November 12 at 11,30am.
Please visit www.bio.org/biochina for more information.
Luqa Pharmaceuticals is a China-focused company. We acquire, develop and commercialize innovative healthcare products that bring added value to prescribers and other healthcare providers while enhancing quality of life for patients. Since its inception in 2010, Luqa has become a fast-growing revenue generating company with a broad product portfolio and pipeline. We aim to become a leader in specialty care segments in China. Please visit us at www.luqapharma.com.